{"filing":{"accession_number":"0001040130-26-000047","cik":"0001040130","ticker":"PETS","company_name":"PETMED EXPRESS INC","form":"8-K","filing_date":"2026-09-21","report_date":"2026-09-15","primary_document":"pets-20260915.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000047/pets-20260915.htm"},"events":[{"id":33897,"run_id":31203,"accession_number":"0001040130-26-000047","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"PetMed Express appointed Tamar Elkeles, Ph.D., as an independent director effective September 17, 2026, increasing the Board to 5 members. Dr. Elkeles was immediately appointed to the Compensation and Human Capital Committee and Corporate Governance and Nominating Committee, and designated as Chair of the Compensation Committee.","company_name":"PETMED EXPRESS INC","ticker":"PETS","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":[{"id":37487,"accession_number":"0001040130-26-000047","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Tamar Elkeles, Ph.D., as a director of PetMed Express effective September 17, 2026, with the Board increasing to 5 members. Dr. Elkeles was immediately appointed to the Compensation and Human Capital Committee and Corporate Governance and Nominating Committee, and designated as Chair of the Compensation Committee. This is a clear executive/director appointment event. The disclosure is material as it involves board composition changes and the addition of an independent director with significant experience in human capital strategy during a period of leadership transition (following the recent CEO appointment of Jeff Willard).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T12:36:44.828891+00:00","company_name":"","ticker":null,"filing_date":""},{"id":37488,"accession_number":"0001040130-26-000047","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. Tamar Elkeles as a new independent director and Chair of the Compensation and Human Capital Committee, effective September 17, 2026. This is a material governance event involving the addition of a board member with significant executive experience in human capital strategy at major technology companies. The appointment is the principal action disclosed in the press release and Item 7.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T12:36:44.828891+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37487,"accession_number":"0001040130-26-000047","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Tamar Elkeles, Ph.D., as a director of PetMed Express effective September 17, 2026, with the Board increasing to 5 members. Dr. Elkeles was immediately appointed to the Compensation and Human Capital Committee and Corporate Governance and Nominating Committee, and designated as Chair of the Compensation Committee. This is a clear executive/director appointment event. The disclosure is material as it involves board composition changes and the addition of an independent director with significant experience in human capital strategy during a period of leadership transition (following the recent CEO appointment of Jeff Willard).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T12:36:44.828891+00:00","company_name":"PETMED EXPRESS INC","ticker":"PETS","filing_date":"2026-09-21"},{"id":37488,"accession_number":"0001040130-26-000047","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. Tamar Elkeles as a new independent director and Chair of the Compensation and Human Capital Committee, effective September 17, 2026. This is a material governance event involving the addition of a board member with significant executive experience in human capital strategy at major technology companies. The appointment is the principal action disclosed in the press release and Item 7.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T12:36:44.828891+00:00","company_name":"PETMED EXPRESS INC","ticker":"PETS","filing_date":"2026-09-21"}]}